- Exchange: EN Paris
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
BioAlliance Pharma SA
Add to PortfolioBIO:FP
3.2200 EUR 0.0400 1.26%As of 10:45:30 ET on 05/25/2012.
Snapshot for BioAlliance Pharma SA (BIO)
| Open: | 3.2300 | Day's Range: | 3.2000 - 3.3000 | Volume: | 35,981 | Bid: | 3.2300 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 3.1800 | 52wk Range: | 2.8000 - 6.3074 | 1-Yr Rtn: | -45.18% | Ask: | 3.2500 |
Key Statistics for BIO
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share () (ttm) | -0.8069 |
| Est. EPS (12/2012) | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 56.86 |
| Shares Outstanding (M) | 17.66 |
| Enterprise Value (M EUR) (ttm) | 42.73 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 4.4231 |
| Price/Sale (ttm) | 18.0396 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 09/21/2012 |
More BIO Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for BIO
- Operating
- Investing
- Financing (M/EUR)
Company Profile & Key Executives for BIO
BioAlliance Pharma is a biopharmaceutical company specialized in the development of therapeutics targeting drug resistance in cancer, HIV and other severe and opportunistic infections. The Company addresses worldwide markets in the EU, US and Asia.
| Patrick LangloisChairman | Judith Christine GrecietChief Executive Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page